<p><b>Copyright information:</b></p><p>Taken from "Pramlintide in the Management of Insulin-Using Patients with Type 2 and Type 1 Diabetes"</p><p></p><p>Vascular Health and Risk Management 2006;2(3):203-212.</p><p>Published online Jan 2006</p><p>PMCID:PMC1993989.</p><p>© 2006 Dove Medical Press Limited. All rights reserved</p
<p><b>Copyright information:</b></p><p>Taken from "Role of the vasodilator peptide angiotensin-(1–7)...
Obesity is a common problem that can lead to numerous comorbid conditions, including Type 2 diabetes...
Copyright © 2013 Wen-shan Lv et al. This is an open access article distributed under the Creative Co...
<p><b>Copyright information:</b></p><p>Taken from "Pramlintide in the Management of Insulin-Using Pa...
<p><b>Copyright information:</b></p><p>Taken from "Pramlintide in the Management of Insulin-Using Pa...
<p><b>Copyright information:</b></p><p>Taken from "Pramlintide in the Management of Insulin-Using Pa...
<p><b>Copyright information:</b></p><p>Taken from "Pramlintide in the Management of Insulin-Using Pa...
John Pullman1, Tamara Darsow2, Juan P Frias21Mercury Street Medical Group, Butte, MT, USA; 2Amylin P...
Derived from .<p><b>Copyright information:</b></p><p>Taken from "Pramlintide, the synthetic analogue...
Pramlintide is a human amylin analog, under development by Amylin (originally in collaboration with ...
PURPOSE We conducted a study to examine the effi cacy, effectiveness, and harms of pramlintide as ad...
Abstract: Tight glycemic control in type 1 and type 2 diabetes reduces the risk for microvascular co...
Byron J Hoogwerf, Krupa B Doshi, Dima DiabDepartment of Endocrinology, Diabetes and Metabolism, Clev...
Diabetes affects approximately 18 million adults in the United States. Diabetes increases the risk o...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
<p><b>Copyright information:</b></p><p>Taken from "Role of the vasodilator peptide angiotensin-(1–7)...
Obesity is a common problem that can lead to numerous comorbid conditions, including Type 2 diabetes...
Copyright © 2013 Wen-shan Lv et al. This is an open access article distributed under the Creative Co...
<p><b>Copyright information:</b></p><p>Taken from "Pramlintide in the Management of Insulin-Using Pa...
<p><b>Copyright information:</b></p><p>Taken from "Pramlintide in the Management of Insulin-Using Pa...
<p><b>Copyright information:</b></p><p>Taken from "Pramlintide in the Management of Insulin-Using Pa...
<p><b>Copyright information:</b></p><p>Taken from "Pramlintide in the Management of Insulin-Using Pa...
John Pullman1, Tamara Darsow2, Juan P Frias21Mercury Street Medical Group, Butte, MT, USA; 2Amylin P...
Derived from .<p><b>Copyright information:</b></p><p>Taken from "Pramlintide, the synthetic analogue...
Pramlintide is a human amylin analog, under development by Amylin (originally in collaboration with ...
PURPOSE We conducted a study to examine the effi cacy, effectiveness, and harms of pramlintide as ad...
Abstract: Tight glycemic control in type 1 and type 2 diabetes reduces the risk for microvascular co...
Byron J Hoogwerf, Krupa B Doshi, Dima DiabDepartment of Endocrinology, Diabetes and Metabolism, Clev...
Diabetes affects approximately 18 million adults in the United States. Diabetes increases the risk o...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
<p><b>Copyright information:</b></p><p>Taken from "Role of the vasodilator peptide angiotensin-(1–7)...
Obesity is a common problem that can lead to numerous comorbid conditions, including Type 2 diabetes...
Copyright © 2013 Wen-shan Lv et al. This is an open access article distributed under the Creative Co...